NHI CEO exercises 151,667 options at set strike prices (NYSE: NHI)

Rhea-AI Filing Summary

National Health Investors CEO and President Eric D. Mendelsohn, who is also a director, reported multiple equity transactions dated January 15, 2026. He exercised several tranches of stock options, acquiring common stock in amounts of 41,666, 41,666, 41,668, 13,334 and 13,333 shares at exercise prices of $69.2, $69.2, $69.2, $54.73 and $57.76 per share, respectively, all held directly.

The filing also lists a separate transaction coded "F" for 135,295 shares of common stock at $79.23 per share, after which Mendelsohn directly owned 112,505 shares of National Health Investors common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mendelsohn D. Eric

(Last) (First) (Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M		41,666	A	$69.2	137,799	D
Common Stock	01/15/2026		M		41,666	A	$69.2	179,465	D
Common Stock	01/15/2026		M		41,668	A	$69.2	221,133	D
Common Stock	01/15/2026		M		13,334	A	$54.73	234,467	D
Common Stock	01/15/2026		M		13,333	A	$57.76	247,800	D
Common Stock	01/15/2026		F		135,295	D	$79.23	112,505	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy) 2-25-2021	$69.2	01/15/2026		M			41,666	02/25/2021	02/25/2026	Common Stock	41,666	$0	0	D
Stock Options (Right to Buy) 2-25-2021	$69.2	01/15/2026		M			41,666	02/25/2022	02/25/2026	Common Stock	41,666	$0	0	D
Stock Options (Right to Buy) 2-25-2021	$69.2	01/15/2026		M			41,668	02/25/2023	02/25/2026	Common Stock	41,668	$0	0	D
Stock Option (Right to Buy) 2023	$54.73	01/15/2026		M			13,334	02/24/2025	02/24/2028	Common Stock	13,334	$0	0	D
Stock Option (Right to Buy) 2024	$57.76	01/15/2026		M			13,333	02/23/2025	02/23/2029	Common Stock	13,333	$0	0	D

Explanation of Responses:

	/s/ Kimberly V. Ouimet, by limited power of attorney	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider in National Health Investors (NHI) Form 4?

The insider is Eric D. Mendelsohn, who serves as CEO, President, and a director of National Health Investors.

What stock option exercises did NHI CEO Eric Mendelsohn report?

On January 15, 2026, he exercised several stock options, acquiring common stock in blocks of 41,666, 41,666, 41,668, 13,334 and 13,333 shares at exercise prices of $69.2, $69.2, $69.2, $54.73 and $57.76 per share.

What is the transaction coded "F" in the NHI Form 4?

The Form 4 shows a non-derivative transaction coded "F" for 135,295 shares of common stock at $79.23 per share, reported as a direct holding transaction.

How many NHI shares does Eric Mendelsohn own after these transactions?

Following the reported transactions on January 15, 2026, Eric Mendelsohn directly owned 112,505 shares of National Health Investors common stock.

Are the NHI Form 4 transactions direct or indirect holdings?

All reported positions in the excerpt are listed as direct (D) ownership, with no nature of indirect beneficial ownership specified.

What derivative securities were involved in the NHI CEO's Form 4?

The derivative transactions involved stock options (rights to buy) granted in 2021, 2023, and 2024, each converted into common stock and shown with zero derivative securities remaining after exercise.